Clarinex-D 12 Hour regulatory update

FDA approved an NDA for Clarinex-D 12 hour extended-release tablets to treat nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in patients ages 12 and older. The ...